← FDA Drug Approvals (Drugs@FDA)
DIAZEPAM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NAVINTA LLC · Approved 2025-11-14
Drug application
- FDA Application #
ANDA217468- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DIAZEPAM
- Generic name
- DIAZEPAM
- Active ingredients
- DIAZEPAM
- Dosage form
- GEL
- Route
- RECTAL
- Marketing status
- Prescription
- Sponsor
- NAVINTA LLC
- Manufacturer
- Navinta LLC
- First approval
- 2025-11-14
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown